Accéder au contenu
Merck

Novel H3 receptor antagonists with improved pharmacokinetic profiles.

Bioorganic & medicinal chemistry letters (2008-06-17)
Vincent J Santora, Jonathan A Covel, Rena Hayashi, Brian J Hofilena, Jason B Ibarra, Michelle D Pulley, Michael I Weinhouse, Graeme Semple, Albert Ren, Guilherme Pereira, Jeffrey E Edwards, Marissa Suarez, John Frazer, William Thomsen, Erin Hauser, Jodie Lorea, Andrew J Grottick
RÉSUMÉ

A new series of H(3) antagonists derived from the natural product Conessine are presented. Several compounds from these new series retain the potency and selectivity of earlier diamine based analogs while exhibiting improved PK characteristics. One compound (3u) demonstrated functional antagonism of the H(3) receptor in an in vivo pharmacological model.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Conessine, ≥97% (HPLC)